Skip to Main Content
  • Login
  • Contact Us
  • Donate

NANETS

  • About
    • Mission
    • Board of Directors
    • NANETS Structure
    • Staff
    • Committees
    • Committee Descriptions
    • NANETS Presidents
    • Lifetime Achievement
    • Outstanding Service
    • History
    • Diversity Statement
    • NANETS Awards
  • Education
    • NETCast Podcast Series
    • Regional NET Education
    • Virtual Programming Series
    • 2026 NET Medical Symposium
    • Conference Archives
    • About NETs
    • NANETS Call for Topics Calendar
  • Research
    • Abstracts Library
    • Abstract Instructions
    • Research Grants
    • Grant Recipients
  • Guidelines
  • Resources
    • Grant Resources
    • NANETS Mentorship Program
    • Employment Postings
    • Clinical Trials
    • Member DirectoryMember Directory
    • NET Around the World
    • Patient Resources
    • Women in NETs
    • COVID-19 Resource Page
    • NANETS Collaboration Submission Form
    • Provider Resources
  • News
    • NET eNews
    • Media
    • Endocrine-Related CancerEndocrine-Related Cancer
    • Photo Gallery
  • Membership
    • Member Login
    • Member Benefits
    • Member Categories
    • Join NOW
    • Spread the Word
    • Code of Conduct
  • 2025

  • 2024

  • 2023

  • 2022

  • 2021

  • 2020

  • 2019

  • 2018

  • 2017

  • 2016

  • 2015

  • 2014

  • 2013

  • 2012

  • 2011

  • 2010

  • 2009

[C27] Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases

Published in 2024 Listed under Clinical

Download

[C26] Meredith - Incidence and Characterization of Carcinoid Crises post Embolization of Neuroendocrine Tumor Liver Metastases

Published in 2024 Listed under Clinical

Download

[C25] Poster - O'Leary - Associations between patterns of neuroendocrine liver metastatic burden and outcomes after embolization, CapTem and PRRT

Published in 2024 Listed under Clinical, Poster

Download

[C25] O'Leary - Does Liver Tumor Morphology Predict Outcomes after LDT, PRRT or CapTem?

Published in 2024 Listed under Clinical

Download

[C24] Barnett - Evaluating Time to Treatment Start for Patients Receiving Peptide Receptor Radioligand Therapy

Published in 2024 Listed under Clinical

Download

[C23] Poster - Porfido - Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with 177Lu - DOTATATE

Published in 2024 Listed under Clinical, Poster

Download

[C23] Porfido - Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with 177Lu-DOTATATE

Published in 2024 Listed under Clinical

Download

[C22] Poster - Porfido - Multicenter clinical registry of patients with a neuroendocrine tumor (NET) diagnosis receiving 177Lu - DOTATATE

Published in 2024 Listed under Clinical, Poster

Download

[C22] Porfido - Multicenter clinical registry of patients with a neuroendocrine tumor (NET) diagnosis receiving 177Lu-DOTATATE

Published in 2024 Listed under Clinical

Download

[C21] del Rivero - Effect of Absorbed Dose on Toxicity and Tumor Response of Lu-177-DOTATATE With Olaparib in Gastroenteropancreatic Neuroendocrine Patients: Preliminary Results

Published in 2024 Listed under Clinical

Download

[C20] Sriwastwa - Imaging, Clinical, and Safety Outcomes in Metastatic Neuroendocrine Tumor Patients Treated with Peptide Receptor Radionuclide Therapy in the Midwestern USA

Published in 2024 Listed under Clinical

Download

[C1] Poster - Mohamed - NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A PIlot Study

Published in 2024 Listed under Clinical, Poster

Download

[C1] Mohamed - NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A Pilot Study

Published in 2024 Listed under Clinical

Download

[C19] Poster - Mosalem - Safety of Lutetium-177 DOTATATE Treatment in Patients with Advanced Neuroendocrine Tumors and Extensive/Innumerable Bone Metastases

Published in 2024 Listed under Clinical, Poster

Download

[C19] Moselam - Safety of Lutetium-177 DOTATATE Treatment in Patients with Advanced Neuroendocrine Tumors and Extensive/ Innumerable Bone Metastases

Published in 2024 Listed under Clinical

Download

[C18] del Rivero - DNA Damage Repair Mutational Status’s Effect on Lu-177- DOTATATE in Combination with Olaparib in Metastatic SSTR+ GI Neuroendocrine Tumor: Preliminary Results

Published in 2024 Listed under Clinical

Download

[C17] Halperin - ACTION-1 phase Ib/3 trial of RYZ101 in gastroenteropancreatic neuroendocrine tumors progressing after 177Lu somatostatin analogue therapy: Phase 1b safety/efficacy

Published in 2024 Listed under Clinical

Download

[C16] Strosberg - Targeted Alpha Therapy with 212Pb-DOTAMTATE in subjects with advanced somatostatin receptor-expressing gastroenteropancreatic neuroendocrine tumors

Published in 2024 Listed under Clinical

Download

[C15] Shaheen - RECIST for the real world: Impact of Response Evaluation Criteria in Solid Tumors compared to standard radiology reports on physician decisions and patient satisfaction

Published in 2024 Listed under Clinical

Download

[C15] Poster - Shaheen - RECIST for the real world: Impact of Response Evaluation Criteria in Solid Tumors compared to standard radiology reports on p hys ician decisions and patient satisfaction

Published in 2024 Listed under Clinical, Poster

Download

[C14] Shrestha - Approach Integrating ERCP with Radiofrequency Ablation for Long-term Management for metastatic pancreatic NET to biliary tree as klatskin tumor

Published in 2024 Listed under Clinical

Download

[C13] Poster - Mulla - Patterns of long-term remission or apparent cure in a cohort of patients with grade 3 neuroendocrine neoplasms (NENs)

Published in 2024 Listed under Clinical, Poster

Download

[C13] Mulla - Patterns of long-term remission or apparent cure in a cohort of patients with grade 3 neuroendocrine neoplasms (NENs)

Published in 2024 Listed under Clinical

Download

[C12] Capdevila - Updated Phase 1 data for the DLL3/CD3 IgG-like T-cell engager BI 764532 in DLL3-positive tumors: focus on extrapulmonary neuroendocrine carcinomas

Published in 2024 Listed under Clinical

Download

[C11] Pattnaik - Survivin and DLL-3 as predictors of survival in low-grade neuroendocrine tumor patients

Published in 2024 Listed under Clinical

Download

[C10] Strosberg - RZ358 (Ersodetug) as a Novel Therapy for Hypoglycemia due to Tumor Hyperinsulinism: Outcomes from an Expanded Access Program for Compassionate Use

Published in 2024 Listed under Clinical

Download

[B9] Forsythe - Establishment of a long term gastric neuroendocrine tumor organoid and matched patient derived xenograft

Published in 2024 Listed under Basic Science

Download

[B8] Guenter - Surface calreticulin induction by doxorubicin in a patient derived xenograft model of pancreatic neuroendocrine carcinoma

Published in 2024 Listed under Basic Science

Download

[B7] Yellapragada - The Role of Cancer Associated Fibroblasts on the Growth of Pancreatic Neuroendocrine Tumors

Published in 2024 Listed under Basic Science

Download

[B6] Pelle - A novel hormone based anti-SSTR bispecific T-cell engager for the treatment of neuroendocrine tumors

Published in 2024 Listed under Basic Science

Download

[B5] Makinen - Single-nucleus transcriptome profiling of enterochromaffin cells in SI-NET patients

Published in 2024 Listed under Basic Science

Download

[B4] Duan - Hedgehog signaling drives glial cell plasticity and oncogenic reprogramming in gastroenteropancreatic neuroendocrine tumors

Published in 2024 Listed under Basic Science

Download

[B3] Yossef - Investigating the Role of Oncometabolites in von Hippel Lindau disease-related Pancreatic Neuroendocrine Neoplasms

Published in 2024 Listed under Basic Science

Download

[B2] Yogo - Spatial Transcriptomics of Multifocal Ileal Neuroendocrine Tumors Reveals Tumor Heterogeneity based on Tumor Microenvironment and New Biomarkers

Published in 2024 Listed under Basic Science

Download

[B2] Poster - Yogo - Spatial Transcriptomics of Multifocal Ileal Neuroendocrine Tumors Reveals Tumor Heterogeneity based on Tumor Microenvironment and New Biomarkers

Published in 2024 Listed under Basic Science, Poster

Download

[B28] Skill - Stratification of neuroendocrine tumors for ecto-5-nucleotidase expression for clinical trials

Published in 2024 Listed under Basic Science

Download

[B28] Poster - Skill - Stratification of neuroendocrine tumors for ecto - 5 - nucleotidase expression for clinical trials

Published in 2024 Listed under Basic Science, Poster

Download

[B27] Poster - Kulathunga - Use of patient-derived pre-clinical models to identify new and effective treatments for neuroendocrine tumors

Published in 2024 Listed under Basic Science, Poster

Download

[B27] Kulathunga - Use of patient-derived pre-clinical models to identify new and effective treatments for neuroendocrine tumors

Published in 2024 Listed under Basic Science

Download

[B26] Pu - Leveraging Cell Mass Measurements To Assess Drug Efficacy For Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases And Advanced Adrenocortical Carcinoma

Published in 2024 Listed under Basic Science

Download

[B25] Kidd - NETest® 2.0 – A Decade of Innovation in Neuroendocrine Tumor/Neoplasm Diagnostics

Published in 2024 Listed under Basic Science

Download

[B24] Sundby - Cell-free methylation signatures non-invasively distinguish patients with MEN1 and provide insights into the biology underlying dpNETs

Published in 2024 Listed under Basic Science

Download

[B23] Zhao - A Novel Nonpeptide Drug Conjugate (NDC) for the Treatment of Somatostatin Receptor 2-Expressing Tumors

Published in 2024 Listed under Basic Science

Download

[B22] Poster - Chaoul - TILs from panNET liver metastases: in search of novel adoptive transfer strategies for the treatment of NETs

Published in 2024 Listed under Basic Science, Poster

Download

[B22] Chaoul - TILs from panNET liver metastases: in search of novel adoptive transfer strategies for the treatment of NETs

Published in 2024 Listed under Basic Science

Download

[B21] Guo - Therapeutic Targeting of SDHB-Deficient Tumors

Published in 2024 Listed under Basic Science

Download

[B20] Xu - Spatial analysis of the tumor microenvironment in pancreatic neuroendocrine tumors

Published in 2024 Listed under Basic Science

Download

[B20] Poster - Heaphy - Spatial analysis of the tumor microenvironment in pancreatic neuroendocrine tumors

Published in 2024 Listed under Basic Science, Poster

Download

[B1] Poster - Yi - Development of innovative in vitro and in vivo patient-derived cancer models for translational studies in G1/G2 gastroenteropancreatic neuroendocrine tumors

Published in 2024 Listed under Basic Science, Poster

Download

[B1] Liu - Development of innovative in vitro and in vivo patient- derived cancer models for translational studies in G1/G2 gastroenteropancreatic neuroendocrine tumors

Published in 2024 Listed under Basic Science

Download

[B19] Paulson - Activity of nab-Sirolimus Alone or in Combination with Cabozantinib, Octreotide, or Talazoparib in Nonclinical Neuroendocrine Tumor Models

Published in 2024 Listed under Basic Science

Download

[B18] Poster - Mohamed - Uncovering genomic differences between small and large cell extra-pulmonary neuroendocrine carcinomas

Published in 2024 Listed under Basic Science, Poster

Download

[B18] Mohamed - Uncovering genomic differences between small and large cell extra-pulmonary neuroendocrine carcinomas

Published in 2024 Listed under Basic Science

Download

[B17] Poster - Mohamed - Molecular landscape of extra-pulmonary small cell neuroendocrine carcinomas based on site of origin

Published in 2024 Listed under Basic Science, Poster

Download

[B17] Mohamed - Molecular landscape of extra-pulmonary small cell neuroendocrine carcinomas based on site of origin

Published in 2024 Listed under Basic Science

Download

[B16] Poster - Mohamed - Comparison of pulmonary versus extra-pulmonary small cell neuroendocrine carcinomas demonstrate distinct genomic alterations

Published in 2024 Listed under Basic Science, Poster

Download

[B16] Mohamed - Comparison of pulmonary versus extra-pulmonary small cell neuroendocrine carcinomas demonstrate distinct genomic alterations

Published in 2024 Listed under Basic Science

Download

[B15] Amegble - CDK4/6 and MEK are actionable, therapeutic targets in pancreatic and lung neuroendocrine tumors (NETs)

Published in 2024 Listed under Basic Science

Download

[B14] Chen - Deletion of Notch1 inhibits pancreatic neuroendocrine tumor growth in vivo

Published in 2024 Listed under Basic Science

Download

[B13] Gillis - Transcriptome alterations in pancreatic neuroendocrine tumors among those living with adverse social determinants of health

Published in 2024 Listed under Basic Science

Download

[B12] Robledo - Combination of angiogenesis and HIF-2 α blockade: synergistic pair worth exploring in neuroendocrine tumors

Published in 2024 Listed under Basic Science

Download

[B12] Poster - Robledo - Combination of angiogenesis and HIF - 2α blockade: synergistic pair worth exploring in neuroendocrine tumors

Published in 2024 Listed under Basic Science, Poster

Download

[B11] Pu - Phosphoproteomic Mass Spectrometry Reveals A Novel Therapeutic Target in Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Published in 2024 Listed under Basic Science

Download

[B10] Forsythe - Development of GEP-NEN Patient Derived Organoids for Long Term Culture and Therapy Screening

Published in 2024 Listed under Basic Science

Download

NANETS 2024 Symposium Abstract C 1 (1)

Published in 2024

Download
  • «
  • 1
  • 2

NANETS

167 Madison Avenue, Suite 205, #646 | New York, NY 10016
(718) 283-4783 | staff@nanets.net

Member Login

Twitter Facebook LinkedIn
  • Privacy Policy
  • |
  • Site Map

Copyright ©2026 ADG. All Rights Reserved | Web Design & Development by ADG Creative, a division of ADG.
ADG is a certified Women Owned Business.